Kira Pharmaceuticals

Kira Pharmaceuticals

Biotechnology, Cambridge, Massachusetts, United States, 11-50 Employees

kirapharma.com

  • LinkedIn

phone no Phone Number: 48********

Who is KIRA PHARMACEUTICALS

Kira Pharmaceuticals is a clinical-stage, global biotechnology company pioneering a world free from complement disease. Enabled by its LOGIC platform, the company has developed a robust p...

Read More

map
  • Cambridge, Massachusetts, United States Headquarters: Cambridge, Massachusetts, United States
  • 2017 Date Founded: 2017
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from KIRA PHARMACEUTICALS

Kira Pharmaceuticals Org Chart and Mapping

Employees

Maura Williams

Business Operations Manager

Yanjie Gu

Senior Director, Cmc

Xiang Gao

VP, Translational Sciences

Yanjie Gu

Senior Director, Cmc

Juliet Rivera

Business and HR Operations

Richard Lee

Chief Medical Officer

Christina Weng

Head of Business Development & Strategy

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Kira Pharmaceuticals

Answer: Kira Pharmaceuticals's headquarters are located at Cambridge, Massachusetts, United States

Answer: Kira Pharmaceuticals's phone number is 48********

Answer: Kira Pharmaceuticals's official website is https://kirapharma.com

Answer: Kira Pharmaceuticals's revenue is Under $1 Million

Answer: Kira Pharmaceuticals's SIC: 2834

Answer: Kira Pharmaceuticals's NAICS: 325412

Answer: Kira Pharmaceuticals has 11-50 employees

Answer: Kira Pharmaceuticals is in Biotechnology

Answer: Kira Pharmaceuticals contact info: Phone number: 48******** Website: https://kirapharma.com

Answer: Kira Pharmaceuticals is a clinical-stage, global biotechnology company pioneering a world free from complement disease. Enabled by its LOGIC platform, the company has developed a robust pipeline of nine (9) novel complement assets focused on validated targets across the complement cascade. With an experienced team of complement biology experts, drug developers, protein engineers and leaders from across the pharma and biotech industry, Kira Pharmaceuticals is uniquely positioned to tackle some of the most complex and toughest challenges in the complement space and to deliver first-in-class and best-in-class therapies to transform the lives of patients. The company is headquartered in Cambridge, Massachusetts with offices in Suzhou and Shanghai, China, and Australia.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access